REFERENCES
- Shebl S S, el-Sharkawy HM, el-Fadaly NH. Haemostatic disorders in non-splenectomized and splenectomized thalassaemic children. East Mediterr Health J 1999; 5: 1171–1177
- Cappellini M D, Robbiolo L, Bottasso B M, Coppola R, Fiorelli G, Mannucci A P. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 2000; 111: 467–473
- Eldor A, Rachmilewitz E A. The hypercoagulable state in thalassemia. Blood 2002; 99: 36–43
- Visudhiphan S, Ketsa-Ard K, Piankijagum A, Tumliang S. Blood coagulation and platelet profiles in persistent post-splenectomy thrombocytosis: the relationship to thromboembolism. Biomed Pharmacother 1985; 39: 264–271
- Shirahata A, Funahara Y, Opartkiattikul N, Fucharoen S, Laosombat V, Yamada K. Protein C and protein S deficiency in thalassemic patients. Southeast Asian J Trop Med Public Health 1992; 23: 65–73
- Akar N, Kemahli S, Akar E. Common genetic variants in patients with chronic hemolytic disease and post splenectomy thrombotic events. Turk J Haematol 1999; 16: 41–42
- Canatan D, Zorlu M, Bayir N. Thrombosis after splenectomy in patients with thalassemia. Turk J Haematol 2001; 18: 259–263
- Kemahli S, Gurman C, Eoin Y. Hypercoagulability in children with thalassemia major. Clin Appl Throm Hemost 1997; 3: 129–132
- Eldor A, Durst R, Hy-Am E. A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. Br J Haematol 1999; 107: 739–746